Presentation is loading. Please wait.

Presentation is loading. Please wait.

New ARV-based prevention tools how the research is happening how we need to be involved Anna Forbes, MSS Consultant, HIV and women’s health HIV Research.

Similar presentations


Presentation on theme: "New ARV-based prevention tools how the research is happening how we need to be involved Anna Forbes, MSS Consultant, HIV and women’s health HIV Research."— Presentation transcript:

1 new ARV-based prevention tools how the research is happening how we need to be involved Anna Forbes, MSS Consultant, HIV and women’s health HIV Research Catalyst Forum 21 May 2010

2 differences between treatment trials and prevention trials HIV treatment trials: enroll those who need treatment & may get immediate benefit may help prevent disease progression only benefits those with the disease HIV prevention trials: enrolling healthy people – no immediate benefit to person may help prevent disease transmission benefits society; everyone at risk of HIV

3 PrEP Clean injecting equipment Cervical barriers: vaginal diaphragms PMTCT Vaccines Voluntary counselling and testing HIV Prevention Microbicides Male and female condoms Male circumcision PEP

4 what do we need to know? Is the product safe? For whom?  Adolescents? Women – pregnant? breast-feeding?  HIV-negative only? Or HIV-positive also?  Topical products -- vaginal application only? rectal only? Is it effective? For whom?  e.g. circumcision: lowers men’s risk, not women’s Usable with condoms/other barriers?

5 early-stage concepts preclinical testing human safety trials 3 in large-scale efficacy trials the product pipeline Source: Alliance for Microbicide Development

6 expected trial results -- effectiveness 201020112012+ PrEP Men who have sex with men PrEP Heterosexual men/women PrEP Serodiscordant couples PrEP Injection drug users Treatment Serodiscordant couples PrEP Men who have sex with men PrEP Women First ARV-based Microbicide Women PrEP/Microbicid es Women

7 what else do we need to know? Does the community see the as ethical?  What roles do they play in set up, implementation, results distribution? Is the test product acceptable?  Do trial participants use it?  Would people use it in real life, after the trial?

8 going through informed consent Recruitment Participant gets information about the trial in her own language Screening Visit 1: Hears more about trial, gets screened for HIV, STI and pregnancy. Baseline data are collected Screening Visit 2: Gets test results, STI treatment if needed, counselling, info. on trial reinforced Randomization: Participant is assigned by chance to a group Family Planning INFORMED CONSENT to be SCREENED Inform ed conse nt to enrol Condoms + placebo Condoms + experimental gel INFORMED CONSENT to be ENROLLED

9 who says when research is ethical? Researchers and sponsors Community and advocates Ethics committees Ethical research

10 the challenge of adherence Prevention technology trials measure both tool + behavior addHow well tool works + How consistently people use it = How well it prevents transmission Effectiveness rate =

11 educating communities is vital People use a new product when: It is affordable and accessible It works the way they think it will (realistic expectations) Their peers like it and/or use it Its benefit seems worth the effort/cost


Download ppt "New ARV-based prevention tools how the research is happening how we need to be involved Anna Forbes, MSS Consultant, HIV and women’s health HIV Research."

Similar presentations


Ads by Google